Herceptin (R): monoclonal antibody therapy for metastatic breast cancer.
McGahan
L
L
Canadian Coordinating Office for Health Technology Assessment, Canada. lyndam@ccohta.ca
D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D002170:Canada; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000627:therapeutic use; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018719:Erb-b2 Receptor Tyrosine Kinases